Efficacy and safety of transarterial chemoembolization (TACE) in combination with tislelizumab and TKIs versus TACE for the treatment of Intermediate and advanced HCC: A retrospective cohort study

被引：0
|
作者：
Han, Y. [1 ]
Tang, S. [1 ]
Gao, Y. [1 ]
Yan, X. [1 ]
Zhi, W. [1 ]
Gong, T. [1 ]
机构：
[1] Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Dept Intervent Therapy, Beijing, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.10.260
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
240P
引用
收藏
页码：S1494 / S1494
页数：1
相关论文
共 50 条
  • [1] A retrospective study on the efficacy and safety of donafenib combined with transarterial chemoembolization (TACE) and with/without immunotherapy in intermediate-advanced hepatocellular carcinoma (HCC).
    Chen, Cong
    Fu, Shouzhong
    Zhao, Suming
    Yuan, Hongxin
    Dai, Feng
    Gu, Weiwei
    Gu, Zhuxin
    Shi, Rongfeng
    Yang, Xiaohu
    Lu, Xiaohua
    Jia, Pengfei
    Si, Luyi
    Zhao, Hui
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [2] Original Comparison of efficacy and safety between transarterial chemoembolization (TACE) combined with lenvatinib versus TACE combined with sorafenib in the treatment of intermediate and advanced hepatocellular carcinoma
    Xu, Rui
    Ji, Xuebing
    Pei, Xiaohong
    Yu, Yongqiang
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2023, 15 (02): : 1117 - 1128
  • [3] Efficacy and safety of donafenib combined with transarterial chemoembolization (TACE) for treating intermediate/advanced-stage hepatocellular carcinoma (HCC): A retrospective real-world study
    Wei, Ning
    Lu, Dong
    Xiao, Jingkun
    Zhou, Chunze
    Zhang, Xingming
    Xu, Shaobao
    Zhang, Zhengfeng
    Cheng, Delei
    Shi, Changsheng
    Liu, Kaicai
    Gao, Zonggen
    Zhu, Yijiang
    Chu, Senlin
    Yin, Liang
    Su, Mingxue
    Lv, Weifu
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [4] Efficacy, Safety, and Potential Biomarkers of Sunitinib and Transarterial Chemoembolization (TACE) Combination in Advanced Hepatocellular Carcinoma (HCC): Phase II Trial
    Pokuri, Venkata K.
    Tomaszewski, Garin M.
    Ait-Oudhia, Sihem
    Groman, Adrienne
    Khushalani, Nikhil I.
    Lugade, Amit A.
    Thanavala, Yasmin
    Ashton, Edward A.
    Grande, Catherine
    Fetterly, Gerald J.
    Iyer, Renuka
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (04): : 332 - 338
  • [5] Transarterial chemoembolization (TACE) combined with apatinib versus TACE combined with sorafenib in advanced hepatocellular carcinoma patients: a multicenter retrospective study
    Qiu, Zhiyu
    Shen, Lujun
    Jiang, Yiquan
    Qiu, Jiliang
    Xu, Zining
    Shi, Mengting
    Yu, Zhentao
    Ma, Yanping
    He, Wei
    Zheng, Yun
    Li, Binkui
    Wang, Guoying
    Yuan, Yunfei
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (04)
  • [6] Transarterial Chemoembolization (TACE) plus Sorafenib Versus TACE for Intermediate or Advanced Stage Hepatocellular Carcinoma: A Meta-Analysis
    Zhang, Leida
    Hu, Peng
    Chen, Xi
    Bie, Ping
    PLOS ONE, 2014, 9 (06):
  • [7] Efficacy and safety of TACE in combination with sorafenib for the treatment of TACE-refractory advanced hepatocellular carcinoma in Chinese patients: a retrospective study
    Wu, Jianbing
    Li, An
    Yang, Jiajin
    Lu, Yanjun
    Li, Jie
    ONCOTARGETS AND THERAPY, 2017, 10 : 2761 - 2768
  • [8] Transarterial chemoembolization (TACE) plus apatinib-combined therapy versus TACE alone in the treatment of intermediate to advanced hepatocellular carcinoma patients: A real-world study
    Wang, Hui
    Liu, Donghui
    Wang, Chu
    Yu, Shilong
    Jin, Gang
    Wang, Chun
    Zhang, Beiguang
    Zhang, Dongxu
    Shao, Dan
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2022, 46 (06)
  • [9] Transarterial Chemoembolization (TACE) Combined With Sorafenib versus TACE in Patients With BCLC Stage C Hepatocellular Carcinoma - A Retrospective Study
    Patidar, Yashwant
    Chandel, Karamvir
    Condati, Naveen K.
    V. Srinivasan, Shyam
    Mukund, Amar
    Sarin, Shiv K.
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2022, 12 (03) : 745 - 754
  • [10] The Role of Lipiodol in the Treatment of Hepatocellular Carcinoma (HCC) through Transarterial Chemoembolization (TACE)
    Popa, Bogdan Valeriu
    Bratu, Ana Magdalena
    Minoiu, Costin Aurelian
    Turculet, Claudiu
    Ene, Dragos
    Constantinescu, Gabriel
    Ilie, Madalina
    Popescu, Mina
    Badila, Elisabeta
    REVISTA DE CHIMIE, 2015, 66 (03): : 408 - 412
12345